Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CROs May Offer More Objective Monitoring For Gene Therapy - FDA's Noguchi

Executive Summary

Gene therapy clinical trial sponsors may want to consider employing contract research organizations to help achieve more objective and independent monitoring of trial conduct, FDA Cellular and Gene Therapies Division Director Phillip Noguchi, MD, suggested at the Drug Information Association annual meeting June 15 in San Diego.

You may also be interested in...



CBER Gene Therapy Office To Be Established By Oct. 1

CBER's Office of Cells, Tissues & Gene Therapy will address the "evolution" of scientific and regulatory issues, FDA Center for Biologics Evaluation & Research Director Kathryn Zoon, PhD, said May 29

CBER Gene Therapy Office To Be Established By Oct. 1

CBER's Office of Cells, Tissues & Gene Therapy will address the "evolution" of scientific and regulatory issues, FDA Center for Biologics Evaluation & Research Director Kathryn Zoon, PhD, said May 29

FDA Inspecting All NME Applications For Appropriate Clinical Trial Monitoring

FDA's Division of Scientific Investigation has expanded its inspection efforts to examine all new molecular entity applications for appropriate clinical trial monitoring.

Related Content

UsernamePublicRestriction

Register

PS036231

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel